Fluorometholone/sulfacetamide sodium ophthalmic Pregnancy and Breast Feeding Warnings

Fluorometholone/sulfacetamide sodium ophthalmic is also known as: FML-S, FML-S Liquifilm

Overview

If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Fluorometholone/Sulfacetamide Suspension while you are pregnant. It is not known if Fluorometholone/Sulfacetamide Suspension is found in breast milk after use in the eye. Do not breast-feed while using Fluorometholone/Sulfacetamide Suspension.

Fluorometholone/sulfacetamide sodium ophthalmic Pregnancy Warnings

Fluorometholone-sodium sulfacetamide ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies with fluorometholone ophthalmic have revealed evidence of teratogenicity and embryotoxicity following low multiples of the recommended human ophthalmic dose. Sulfonamides have been reported to cross the placenta to the fetus during all stages of gestation. However, even when taken orally, sulfonamides have not been reported to pose a significant teratogenic risk. Systemic sulfonamides have been associated with kernicterus in infants when given during the third trimester. With the maternal blood levels expected when the sodium sulfacetamide is administered by the ophthalmic route, risk to the fetus would be expected to be minimal. There are no controlled data in human pregnancy. Fluorometholone-sodium sulfacetamide ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.

Fluorometholone/sulfacetamide sodium ophthalmic Lactation Warnings

There are no data on the excretion of fluorometholone-sodium sulfacetamide ophthalmic into human milk. Topically applied steroids have been reported to be absorbed systemically. Sulfonamides are excreted into human milk. However, adverse effects in the nursing infant are unlikely from maternal use of sodium sulfacetamide ophthalmic. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue the drug or to discontinue nursing, taking into account the importance of the drug to the mother.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.